thumbnail image

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry
  • OncoGateTM

    AI-powered cancer risk assessment

    OncoGateTM is an AI-based cancer risk assessment (CRA) solution that leverages routine lab testing results (including blood, biochemistry, and urine tests) and age to identify individuals at elevated risk of cancer. It is designed to support risk-stratified screening strategies by prioritizing high-risk individuals for downstream multi-cancer early detection (MCED) testing.

    Highlights

    By enriching high-risk individuals from the general population, OncoGateTM has the potential to improve the efficiency and cost-effectiveness of large-scale cancer screening programs.

    ◉ Reduces screening burden

    Identifies high-risk individuals to focus downstream testing

    ◉ Improves screening efficiency

    Increases positive predictive value and reduces false positives

    ◉ Easy to implement

    Uses routine laboratory tests without additional procedures

    ◉ Widely accessible

    Compatible with existing healthcare systems, suitable for large-scale use

  • Specifications

    ◉ Indicated subjects: adults (≥20 years)

    ◉ Input requirement: routine lab testing results and age

    ◉ Result readout: Personal Cancer Risk Score (PCRS)

    ◉ Turnaround time (TAT): 1 working day

  • How it works

    Section image

    Order

    Consult your doctor to order through a local healthcare partner

    Section image

    Data collection

    Routine lab testing results and patient age are collected from existing clinical workflows

    Section image

    Risk assessment

    OncoGate analyzes the data to generate PCRS and assigns individuals to risk groups (e.g., low-risk or high-risk)

    Section image

    Reporting

    Results are available in 1 working day to support screening and diagnostic decisions

  • Please review the instructions to gain a better understanding of OncoGateTM and assess whether it meets your needs.

    Download the Instructions

Navigation

Technology

SeekInCare

SeeInCure

SeekInClarity

OncoSeek

Research

Contact Us

10320 Camino Santa Fe, Suite G

San Diego, CA 92121

United States

info@seekincancer.com

© 2024 SeekIn Inc.

All Rights Reserved.

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More